Principal Investigator James Collins
Project Start Date February 2020
In February, researchers from MIT and Takeda Pharmaceuticals joined together to celebrate the official launch of the MIT-Takeda Program. The MIT-Takeda Program aims to fuel the development and application of artificial intelligence (AI) capabilities to benefit human health and drug development. Centered within the Abdul Latif Jameel Clinic for Machine Learning in Health (Jameel Clinic), the program brings together the MIT School of Engineering and Takeda Pharmaceuticals, to combine knowledge and address challenges of mutual interest.
Following a competitive proposal process, nine inaugural research projects were selected. The program’s flagship research projects include principal investigators from departments and labs spanning the School of Engineering and the Institute. Research includes diagnosis of diseases, prediction of treatment response, development of novel biomarkers, process control and improvement, drug discovery, and clinical trial optimization.
Engaging with researchers and industry experts from Takeda, each project team will bring together different disciplines, merging theory and practical implementation, while combining algorithm and platform innovations.
The flagship research projects of the MIT-Takeda Program offer real promise to the ways MIT can impact human health.